235 related articles for article (PubMed ID: 28072872)
1. Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.
Hoglund RM; Workman L; Edstein MD; Thanh NX; Quang NN; Zongo I; Ouedraogo JB; Borrmann S; Mwai L; Nsanzabana C; Price RN; Dahal P; Sambol NC; Parikh S; Nosten F; Ashley EA; Phyo AP; Lwin KM; McGready R; Day NP; Guerin PJ; White NJ; Barnes KI; Tarning J
PLoS Med; 2017 Jan; 14(1):e1002212. PubMed ID: 28072872
[TBL] [Abstract][Full Text] [Related]
2. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
Hoglund RM; Adam I; Hanpithakpong W; Ashton M; Lindegardh N; Day NP; White NJ; Nosten F; Tarning J
Malar J; 2012 Nov; 11():398. PubMed ID: 23190801
[TBL] [Abstract][Full Text] [Related]
3. Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria.
Wattanakul T; Baker M; Mohrle J; McWhinney B; Hoglund RM; McCarthy JS; Tarning J
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468477
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
Rijken MJ; McGready R; Phyo AP; Lindegardh N; Tarning J; Laochan N; Than HH; Mu O; Win AK; Singhasivanon P; White N; Nosten F
Antimicrob Agents Chemother; 2011 Dec; 55(12):5500-6. PubMed ID: 21947392
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.
Keating GM
Drugs; 2012 May; 72(7):937-61. PubMed ID: 22515619
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
Tarning J; Ashley EA; Lindegardh N; Stepniewska K; Phaiphun L; Day NP; McGready R; Ashton M; Nosten F; White NJ
Antimicrob Agents Chemother; 2008 Mar; 52(3):1052-61. PubMed ID: 18180343
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
Tarning J; Zongo I; Somé FA; Rouamba N; Parikh S; Rosenthal PJ; Hanpithakpong W; Jongrak N; Day NP; White NJ; Nosten F; Ouedraogo JB; Lindegardh N
Clin Pharmacol Ther; 2012 Mar; 91(3):497-505. PubMed ID: 22258469
[TBL] [Abstract][Full Text] [Related]
10. Piperaquine Population Pharmacokinetics and Cardiac Safety in Cambodia.
Vanachayangkul P; Lon C; Spring M; Sok S; Ta-Aksorn W; Kodchakorn C; Pann ST; Chann S; Ittiverakul M; Sriwichai S; Buathong N; Kuntawunginn W; So M; Youdaline T; Milner E; Wojnarski M; Lanteri C; Manning J; Prom S; Haigney M; Cantilena L; Saunders D
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193647
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
Tarning J; Rijken MJ; McGready R; Phyo AP; Hanpithakpong W; Day NP; White NJ; Nosten F; Lindegardh N
Antimicrob Agents Chemother; 2012 Apr; 56(4):1997-2007. PubMed ID: 22252822
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria.
Hung TY; Davis TM; Ilett KF; Karunajeewa H; Hewitt S; Denis MB; Lim C; Socheat D
Br J Clin Pharmacol; 2004 Mar; 57(3):253-62. PubMed ID: 14998421
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.
Lon C; Manning JE; Vanachayangkul P; So M; Sea D; Se Y; Gosi P; Lanteri C; Chaorattanakawee S; Sriwichai S; Chann S; Kuntawunginn W; Buathong N; Nou S; Walsh DS; Tyner SD; Juliano JJ; Lin J; Spring M; Bethell D; Kaewkungwal J; Tang D; Chuor CM; Satharath P; Saunders D
PLoS One; 2014; 9(3):e93138. PubMed ID: 24667662
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam.
Nguyen DV; Nguyen QP; Nguyen ND; Le TT; Nguyen TD; Dinh DN; Nguyen TX; Bui D; Chavchich M; Edstein MD
Antimicrob Agents Chemother; 2009 Aug; 53(8):3534-7. PubMed ID: 19528277
[TBL] [Abstract][Full Text] [Related]
15. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J
BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
Tarning J; Lindegardh N; Lwin KM; Annerberg A; Kiricharoen L; Ashley E; White NJ; Nosten F; Day NP
Antimicrob Agents Chemother; 2014; 58(4):2052-8. PubMed ID: 24449770
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
19. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.
Thanh NV; Thuy-Nhien N; Tuyen NT; Tong NT; Nha-Ca NT; Dong LT; Quang HH; Farrar J; Thwaites G; White NJ; Wolbers M; Hien TT
Malar J; 2017 Jan; 16(1):27. PubMed ID: 28086775
[TBL] [Abstract][Full Text] [Related]
20. Piperaquine Pharmacokinetics during Intermittent Preventive Treatment for Malaria in Pregnancy.
Chotsiri P; Gutman JR; Ahmed R; Poespoprodjo JR; Syafruddin D; Khairallah C; Asih PBS; L'lanziva A; Otieno K; Kariuki S; Ouma P; Were V; Katana A; Price RN; Desai M; Ter Kuile FO; Tarning J
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
